159 related articles for article (PubMed ID: 31813284)
1. Design, synthesis and anticancer evaluation of β-carboline-1-one hydantoins.
Yao CH; Hsieh TC; Song JS; Lee JC
Future Med Chem; 2020 Feb; 12(3):183-192. PubMed ID: 31813284
[No Abstract] [Full Text] [Related]
2. Design, synthesis and anticancer evaluation of tetrahydro-β-carboline-hydantoin hybrids.
Shankaraiah N; Nekkanti S; Chudasama KJ; Senwar KR; Sharma P; Jeengar MK; Naidu VG; Srinivasulu V; Srinivasulu G; Kamal A
Bioorg Med Chem Lett; 2014 Dec; 24(23):5413-7. PubMed ID: 25453799
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of some β-carboline derivatives as multi-target anticancer agents.
Abdelsalam MA; AboulWafa OM; Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N
Future Med Chem; 2018 Dec; 10(24):2791-2814. PubMed ID: 30539666
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents.
Zhang M; Liang YR; Li H; Liu MM; Wang Y
Bioorg Med Chem; 2017 Dec; 25(24):6623-6634. PubMed ID: 29126741
[TBL] [Abstract][Full Text] [Related]
6. New 3-tetrazolyl-β-carbolines and β-carboline-3-carboxylates with anti-cancer activity.
Panice MR; Lopes SMM; Figueiredo MC; Goes Ruiz ALT; Foglio MA; Nazari Formagio AS; Sarragiotto MH; Pinho E Melo TMVD
Eur J Med Chem; 2019 Oct; 179():123-132. PubMed ID: 31247374
[TBL] [Abstract][Full Text] [Related]
7. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
[TBL] [Abstract][Full Text] [Related]
9. Design of beta-carboline derivatives as DNA-targeting antitumor agents.
Guan H; Chen H; Peng W; Ma Y; Cao R; Liu X; Xu A
Eur J Med Chem; 2006 Oct; 41(10):1167-79. PubMed ID: 16790297
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure--activity relationships of N²-alkylated quaternary β-carbolines as novel antitumor agents.
Zhang G; Cao R; Guo L; Ma Q; Fan W; Chen X; Li J; Shao G; Qiu L; Ren Z
Eur J Med Chem; 2013 Jul; 65():21-31. PubMed ID: 23688697
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents.
Barbosa VA; Baréa P; Mazia RS; Ueda-Nakamura T; Costa WFD; Foglio MA; Goes Ruiz ALT; Carvalho JE; Vendramini-Costa DB; Nakamura CV; Sarragiotto MH
Eur J Med Chem; 2016 Nov; 124():1093-1104. PubMed ID: 27792980
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.
Shi B; Cao R; Fan W; Guo L; Ma Q; Chen X; Zhang G; Qiu L; Song H
Eur J Med Chem; 2013 Feb; 60():10-22. PubMed ID: 23279863
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, anticancer screening, docking studies and in silico ADME prediction of some β-carboline derivatives.
Abdelsalam MA; AboulWafa OM; M Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N; Elaasser MM
Future Med Chem; 2018 May; 10(10):1159-1175. PubMed ID: 29787297
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of β-carboline derivatives with nitrogen mustard moieties against breast cancer.
Sun J; Wang J; Wang X; Hu X; Cao H; Bai J; Li D; Hua H
Bioorg Med Chem; 2021 Sep; 45():116341. PubMed ID: 34365102
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
Ruan XQ; Chen M; Wu WT; You QD
Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.
Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of marine alkaloid-oriented β-carboline analogues.
Xu T; Shi L; Zhang Y; Wang K; Yang Z; Ke S
Eur J Med Chem; 2019 Apr; 168():293-300. PubMed ID: 30826506
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
